Sugi Predict

Sugi Predict / Compounds / SCHEMBL10116010

SCHEMBL10116010

SCHEMBL10116010

CC(C)S(=O)(=O)NC1CCN(C(=O)Nc2ccc(-c3ccccc3)cc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.48
▸ KMT2A Q03164 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ NPY5R Q15761 1/20 0.47
▸ GRIA2 P42262 1/20 0.47
▸ POLB P06746 2/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ FAAH O00519 3/20 0.46
▸ CCR8 P51685 1/20 0.46
▸ EPHX2 P34913 1/20 0.46
▸ TRPV1 Q8NER1 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ NAMPT P43490 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10115849 0.93 ALDH1A1 (0.55) ALDH1A1KMT2AKDM4EPOLBALOX15
SCHEMBL10115925 0.89 NPY5R (0.48) ALDH1A1KMT2AKDM4ENPY5RPOLB
SCHEMBL12882838 0.87 TSHR (0.48) ALDH1A1KMT2AKDM4EPOLBALOX15
SCHEMBL10115847 0.87 LMNA (0.59) KMT2AKDM4EPOLBALOX15FAAH
SCHEMBL13222448 0.87 GAA (0.50) ALDH1A1KMT2APOLBALOX15EPHX2
SCHEMBL10115950 0.87 KMT2A (0.52) ALDH1A1KMT2ACCR8GAALMNA
SCHEMBL10116082 0.87 NPC1 (0.47) KMT2AGRIA2POLBALOX15FAAH
SCHEMBL10115939 0.86 LMNA (0.46) ALDH1A1KMT2AKDM4EPOLBALOX15
SCHEMBL10114601 0.86 KMT2A (0.59) KMT2AEPHX2GAA
SCHEMBL10115852 0.86 NPC1 (0.57) ALDH1A1KMT2AEPHX2TRPV1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-20110039802-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2011-02-17 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015762-A1 NPY Y5 antagonist NPY5R, NPY1R, NPY2R ALDH1A1 4558/4885KMT2A 2912/4885KDM4E 1668/4885
US-20100292500-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R ALDH1A1 4599/4885KMT2A 2768/4885KDM4E 1627/4885
US-20110039802-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R ALDH1A1 4517/4885KMT2A 2953/4885KDM4E 1653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.